AI + mRNA 技术平台亮相研发日:公司近期举办研发日活动,集中展示其完全整合且本地化的AI + mRNA 平台,及基于该平台的多款mRNA 肿瘤药物研发进展:1)个性化肿瘤治疗性疫苗EVM16 目前已在小鼠黑色素瘤模型中验证疗效并展现出与PD-1 抗体存在协同作用。其IIT 研究的初步结果显示,即使低起始剂量,也能在晚期肿瘤患者中激发特异性T 细胞反应,具有良好的免疫原性。2)通用型现货...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.